Sintetica Us Is A Subsidiary Of The Swiss Pharmaceutical Company Sinteticaestablished On July 142022And Headquartered In Princetonnew Jerseythe Company Is Led By President Frank Mullerywho Brings Extensive Experience From Various Senior Leadership Roles In The U Spharmaceutical Industry Sintetica Us Specializes In High Quality Injectable Medicinesfocusing On Anesthesiapain Managementneuromodulationand Intensive Carethe Company Utilizes Its Parent Company S Expertise In Producing Sterile Injectable Solutions From Fda Approved Facilities In Switzerlandsintetica Us Aims To Expand Its Product Offerings With Innovative Solutions Tailored To The U Smarket And Emphasizes Building Strong Partnerships With Healthcare Providers To Enhance Growth And Improve Healthcare Outcomes
